ERCC5

Investigation on ERCC5 genetic polymorphisms and the development of gastric cancer in a Chinese population

L. Q. Yang, Zhang, Y., Sun, H. F., Yang, L. Q., Zhang, Y., and Sun, H. F., “Investigation on ERCC5 genetic polymorphisms and the development of gastric cancer in a Chinese population”, vol. 15, p. -, 2016.

Our study aimed to investigate the role of 2 ERCC5 promoter SNPs (rs2094258 and rs751402) in the development of gastric cancer in the Chinese population. The present hospital-based case-control study consisted of 155 patients with gastric cancer and 246 healthy controls recruited between March 2012 and December 2014. Genotyping for the rs2094258 and rs751402 polymorphic sites was carried out using polymerase chain reaction-restriction fragment length polymorphism. Statistical analyses were conducted using the SPASS version 16.0 software (SPSS, Inc., Chicago, IL, USA).

Association between ERCC5 gene polymorphisms and gastric cancer risk

B. W. Guo, Yang, L., Zhao, R., Hao, S. Z., Guo, B. W., Yang, L., Zhao, R., and Hao, S. Z., “Association between ERCC5 gene polymorphisms and gastric cancer risk”, vol. 15, p. -, 2016.

We investigate the role of ERCC5 gene polymorphisms (rs17655 and rs751402) in the development of gastric cancer in a Chinese population. A total of 142 gastric cancer patients whose diagnoses were confirmed by pathology, and 274 control subjects were recruited from Tangshan Gongren Hospital between March 2013 and March 2015. Genotyping of ERCC5 rs17655 and rs751402 polymorphisms was performed by polymerase chain reaction-restriction fragment length polymorphism.

Lack of association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population

J. J. Lu, Zhang, H. Q., Mai, P., Ma, X., Chen, X., Yang, Y. X., Zhang, L. P., Lu, J. J., Zhang, H. Q., Mai, P., Ma, X., Chen, X., Yang, Y. X., and Zhang, L. P., “Lack of association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population”, vol. 15, p. -, 2016.

We conducted a case-control study to assess the association between single nucleotide polymorphisms in the ERCC5 promoter (rs2094258 and rs751402) and development of gastric cancer in a Chinese population. This investigation included 184 patients with pathologically diagnosed gastric cancer and 206 healthy subjects recruited between October 2012 and December 2014. The genotyping of ERCC5 rs2094258 and rs751402 variants was performed by polymerase chain reaction coupled with restriction fragment length polymorphism.

Association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population

R. J. Li, Li, M., Liu, G. J., Guo, Y. W., Bai, H., Xiao, P., Mei, J. Z., Li, R. J., Li, M., Liu, G. J., Guo, Y. W., Bai, H., Xiao, P., Mei, J. Z., Li, R. J., Li, M., Liu, G. J., Guo, Y. W., Bai, H., Xiao, P., and Mei, J. Z., “Association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population”, vol. 15, p. -, 2016.

We conducted a hospital-based case-control study to investigate the association between 3 common SNPs in the ERCC5 gene (rs1047768, rs751402, and rs17655) and the risk of developing gastric cancer. Between January 2013 and December 2014, samples were collected from 216 gastric cancer patients and 216 control subjects. ERCC5 rs1047768, rs751402, and rs17655 polymorphisms were genotyped by polymerase chain reaction combined with restriction fragment length polymorphism analysis.

Role of XRCC1 and ERCC5 polymorphisms on clinical outcomes in advanced non-small cell lung cancer

D. Liu, Wu, J., Shi, G. Y., Zhou, H. F., and Yu, Y., “Role of XRCC1 and ERCC5 polymorphisms on clinical outcomes in advanced non-small cell lung cancer”, vol. 13, pp. 3100-3107, 2014.

We aimed to assess the role of polymorphisms of the XRCC1 Arg194Trp, XRCC1 Arg399Gln, ERCC5 His1104Asp, and ERCC5 His46His genes on clinical outcomes of advanced non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy regimens. A total of 378 NSCLC patients were asked to participate within 1 month after diagnosis between January 2005 and January 2006, and they were followed up until November 2011. Genomic DNA of the four genes was extracted using the Qiagen Blood Kit.

Subscribe to ERCC5